Global Remdesivir Market Size to Hit USD 11.12 Billion By 2032

Zion Market Research has published a new report titled “Remdesivir Market by Dosage (2.5mg, 5mg, 100mg, 200mg ); by Patient (Adult, Pediatric, and Geriatric); by Application (Ebola, SARS-COV, MERS-COV, COVID-19); By End-user (Hospitals, Clinics, Pharmacy & Drug Stores, Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2024– 2032”. According to the report, global demand for remdesivir market is to grow at a 7.20% CAGR.

Browse the full “Remdesivir Market By Dosage (2.5mg, 5mg, 100mg, 200mg), By Patient (Adult, Pediatric, And Geriatric), By Application (Ebola, SARS-COV, MERS-COV, COVID-19), By End User (Hospitals, Clinics, Pharmacy & Drug Stores, And Online Pharmacies), and By Region – Global Industry Perspective Comprehensive Analysis And Forecast, 2024-2032” Report at https://www.zionmarketresearch.com/report/remdesivir-market

Remdesivir is an analog investigational nucleotide having broad-spectrum antiviral activity in animal models both in vitro and in vivo against several rapidly growing viral pathogens like Ebola, Marburg, MERS and SARS. Gilead in vitro testing has shown that remdesivir is effective against the virus which causes COVID-19. Remdesivir's safety and efficacy for COVID-19 therapy is being tested in several ongoing Phase 3 clinical trials. Remdesivir is investigative as it is still under investigation. There is limited knowledge about the safety and efficacy of using Remdesivir to treat patients with COVID-19 at hospitals. There are no FDA-approved medicines as safe and effective for treating people who have COVID-19 in hospital. The FDA has therefore authorized Remdesivir 's emergency use for the treatment of COVID-19 under an Emergency Use Authorisation (EUA).

Occurrences of pandemics like COVID-19, Ebola, and the growing prevalence of viral diseases will act as major driving factors in the growth of the global Remdesivir market. High investment in research and development to investigate further uses of Remdesivir will act as an opportunity for the market players in the Remdesivir market. Nonetheless, the high cost of Remdesivir will restrict the growth of the global Remdesivir market.

The global Remdesivir market has been fragmented into Dosage, Patient, Application, End-user, and region. Based on Dosage, Global Remdesivir Market is segmented into 2.5mg, 5mg, 100mg, and 200mg. Based on Patient, the Market is segmented into Adult, Pediatric, and Geriatric. Based on Application, the Market is segmented into Ebola, SARS-COV, MERS-COV, and COVID-19. The End user segment of the Remdesivir Market is categorized into Hospitals, Clinics, Pharmacy & Drug Stores, and Online Pharmacies.

Region-wise, the Remdesivir market is segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa. North America will be the leading region during the forecast period. Increasing cases of COVID-19, High prevalence of diseases, easy availability, and presence of leading market players will boost the market growth in this region. Europe will be the second largest market. The major reasons are increasing awareness concerning the use of Remdesivir and the high impact of pandemics like COVID-19. Asia Pacific will proliferate at a speedy rate over the forecast period due to high frequencies of viral disease outbreak, and granting of permission to manufacture Remdesivir by the parent company. The Latin American market will progress at a notable rate during the estimated period. The Middle Eastern and African countries are expected to experience clear growth in the predictable time.

The report also includes detailed profiles of key players such as Gilead Sciences, Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Hetero, Cipla, and Jubilant Lifesciences among others.

The report segment of the global Remdesivir market as follows:

Global Remdesivir Market: By Dosage

• 2.5mg
• 5mg
• 100mg
• 200mg

Global Remdesivir Market: By Patient

• Adult
• Pediatric
• Geriatric

Global Remdesivir Market: By Application

• Ebola
• SARS-COV
• MERS-COV
• COVID-19
  • Invasive mechanical ventilation
  • Non-Invasive mechanical ventilation

Global Remdesivir Market: By End-user

• Hospitals
• Clinics
• Pharmacy & Drug Stores
• Online Pharmacies

Global Remdesivir Market: By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com